Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 94
Filtrar
Más filtros

Medicinas Complementárias
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Exp Parasitol ; 195: 1-7, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30266573

RESUMEN

L-arginine (L-Arg), the precursor of nitric oxide (NO), plays multiple, important roles in nutrient metabolism and immune regulation. Hypoargininemia is one of the distinctive features of malaria patients in endemic areas. To understand the immunoregulatory function of L-Arg in malaria, we investigated the effects of L-Arg, pre- or/and post-treatment, on the cellular/humoral immune response during Plasmodium yoelii 17XL (P.y17XL) infection in DBA/2 mice. Populations of splenic CD4+T-bet+IFN-γ+ T cells (Th1), F4/80+ macrophages, CD4+GATA-3+IL-4+ T cells (Th2), B220+CD138+ plasmacytes and antibody-producing cells (IgG+/IgG1+-plasma cells) were assessed by flow cytometry. Pro-inflammatory cytokines and antibodies (IgG and IgG1) were quantified by immunoassays. We found that treatment with L-Arg significantly decreased parasitemia and shortened disease duration. Prophylactic treatment with L-Arg promotes an enhanced Th1 cell response during the early stages of P.y17XL infection, and treatment with L-Arg in the course of infection facilitates the later humoral immune response. Our findings suggest that treatment with L-Arg may decrease parasite burden and control the host's susceptibility to parasite synchronously by regulating host immune responses against P.y17XL, producing better outcomes for malaria infection. This implies that the supplementation of L-Arg may be a promising adjunctive therapy to reduce malaria-associated mortality in endemic areas.


Asunto(s)
Arginina/uso terapéutico , Malaria/tratamiento farmacológico , Plasmodium yoelii/inmunología , Animales , Anticuerpos Antiprotozoarios/biosíntesis , Anticuerpos Antiprotozoarios/inmunología , Células Productoras de Anticuerpos/efectos de los fármacos , Células Productoras de Anticuerpos/inmunología , Arginina/sangre , Citometría de Flujo , Inmunoglobulina G/biosíntesis , Inmunoglobulina G/sangre , Interferón gamma/metabolismo , Malaria/inmunología , Malaria/prevención & control , Ratones , Ratones Endogámicos DBA , Óxido Nítrico/metabolismo , Parasitemia/tratamiento farmacológico , Parasitemia/prevención & control , Células TH1/efectos de los fármacos , Células TH1/inmunología , Células Th2/citología , Células Th2/efectos de los fármacos , Células Th2/inmunología
2.
Bull Exp Biol Med ; 155(2): 221-3, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24130995

RESUMEN

We observed immunorehabilitation effects of ultrahigh frequency electromagnetic fields (microwaves) in immunocompromised animals. It was shown that microwave irradiation of the thyroid gland area could abolish actinomycin D- and colchicine-induced immunosuppression and did not affect immunosuppression caused by 5-fluorouracil. These findings suggest that changes in the hormonal profile of the organism during microwave exposure can stimulate the processes of transcription and mitotic activity of lymphoid cells.


Asunto(s)
Corteza Suprarrenal/efectos de la radiación , Campos Electromagnéticos , Huésped Inmunocomprometido/efectos de la radiación , Magnetoterapia/métodos , Glándula Tiroides/efectos de la radiación , 11-Hidroxicorticoesteroides/sangre , Corteza Suprarrenal/inmunología , Corteza Suprarrenal/metabolismo , Glándulas Suprarrenales/metabolismo , Glándulas Suprarrenales/efectos de la radiación , Animales , Células Productoras de Anticuerpos/efectos de los fármacos , Células Productoras de Anticuerpos/efectos de la radiación , Colchicina , Dactinomicina , Eritrocitos/inmunología , Eritrocitos/efectos de la radiación , Huésped Inmunocomprometido/inmunología , Terapia de Inmunosupresión , Masculino , Microondas/uso terapéutico , Conejos , Bazo/citología , Glándula Tiroides/inmunología , Glándula Tiroides/metabolismo
3.
Anim Sci J ; 84(4): 322-7, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23590506

RESUMEN

Mortality and morbidity of neonates continue to be major problems in humans and animals, and immunoblogulin A (IgA) provides protection against microbial antigens at mucosal surfaces. The present study was conducted to clarify the effects of coumestrol administration to maternal mice during pregnancy and lactation on IgA antibody-secreting cells (ASC) in mammary glands in lactating mice. From 6.5 to 16.5 days post coitus and 1 to 13 days post partum (dpp), maternal mice were administered coumestrol at 200 µg/kg body weight/day. Coumestrol administration increased the number of IgA ASC and the messenger RNA expression of IgA C-region and vascular cell adhesion molecule-1 in mammary glands of maternal mice at 14 dpp, but coumestrol administration had no effect on the number of IgA ASC in the ileum. Coumestrol administration increased serum IgA concentration in maternal mice at 14 dpp, but IgA concentrations in serum, stomach contents, intestine and feces of neonatal mice were not affected by treatment. These results imply that coumestrol administration to maternal mice during pregnancy and lactation is effective in increasing the numbers of IgA ASC in mammary glands during lactation owing to the activated messenger RNA expressions of IgA C-region and vascular cell adhesion molecule-1 in mammary gland.


Asunto(s)
Células Productoras de Anticuerpos/efectos de los fármacos , Cumestrol/farmacología , Inmunoglobulina A/fisiología , Lactancia , Glándulas Mamarias Animales/citología , Ratones/fisiología , Fitoestrógenos/farmacología , Preñez/efectos de los fármacos , Animales , Células Productoras de Anticuerpos/citología , Cumestrol/administración & dosificación , Femenino , Íleon/citología , Inmunoensayo , Inmunoglobulina A/sangre , Inmunohistoquímica , Ratones Endogámicos ICR , Fitoestrógenos/administración & dosificación , Embarazo , ARN Mensajero/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
4.
Br J Nutr ; 105(1): 24-30, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20727240

RESUMEN

Mortality of neonates continues to be a major problem in humans and animals. IgA provides protection against microbial antigens at mucosal surfaces. Although ß-carotene supplementation has been expected to enhance retinoic acid-mediated immune response in neonates, the exact mechanism by which ß-carotene enhances IgA production is still unclear. We investigated the effect of supplemental ß-carotene for maternal mice during pregnancy and lactation on IgA antibody-secreting cells (ASC) in mammary gland and guts and on IgA transfer from milk to neonatal mice. Pregnant mice were fed untreated or 50 mg/kg ß-carotene-supplemented diets from 6·5 d postcoitus (dpc) to 14 d postpartum (dpp). Supplemental ß-carotene increased the numbers of IgA ASC in mammary gland (P < 0·05) and ileum (P < 0·001), and also mRNA expression of IgA C-region in ileum (P < 0·05) of maternal mice at 14 dpp, but few IgA ASC were detected in mammary gland at 17·5 dpc. IgA concentration in stomach contents, which represents milk IgA level, was significantly higher (P < 0·01) in neonatal mice born to ß-carotene-supplemented mothers at 7 and 14 dpp, and IgA concentration in serum, stomach contents and faeces increased (P < 0·001) drastically with age. These results suggest that ß-carotene supplementation for maternal mice during pregnancy and lactation is useful for enhancing IgA transfer from maternal milk to neonates owing to the increase in IgA ASC in mammary gland and ileum during lactation.


Asunto(s)
Células Productoras de Anticuerpos/efectos de los fármacos , Inmunoglobulina A/metabolismo , Lactancia/inmunología , Glándulas Mamarias Animales/inmunología , Fenómenos Fisiologicos Nutricionales Maternos/inmunología , Leche/inmunología , beta Caroteno/farmacología , Animales , Animales Recién Nacidos , Animales Lactantes , Células Productoras de Anticuerpos/citología , Células Productoras de Anticuerpos/inmunología , Suplementos Dietéticos , Heces/química , Femenino , Contenido Digestivo/química , Íleon/inmunología , Inmunoglobulina A/genética , Masculino , Ratones , Ratones Endogámicos ICR , Embarazo , ARN Mensajero/metabolismo , beta Caroteno/sangre , beta Caroteno/metabolismo
5.
Bull Exp Biol Med ; 151(2): 194-6, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22238748

RESUMEN

The effects of extracts from licorice (Glycyrrhisa glabra), great nettle (Urtica dioica), common burdock (Arctium lappa), and bur marigold (Bidens tripartite) on the humoral and cellular immune response and nonspecific resistance in mice were studied. Burdock and bur marigold extracts stimulated the humoral immune response, nettle and licorice extracts stimulated cellular response and nonspecific resistance, their effects being superior to those of pharmacopoeial Echinacea purpurea tincture.


Asunto(s)
Sistema Inmunológico/efectos de los fármacos , Inmunidad Humoral/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Células Productoras de Anticuerpos/efectos de los fármacos , Células Productoras de Anticuerpos/inmunología , Antígenos/inmunología , Arctium/química , Bidens/química , Recuento de Células , Eritrocitos/inmunología , Glycyrrhiza/química , Masculino , Ratones , Ratones Endogámicos CBA , Ovinos , Bazo/citología , Bazo/efectos de los fármacos , Bazo/inmunología , Urtica dioica/química
6.
Immunopharmacol Immunotoxicol ; 33(1): 73-83, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20367552

RESUMEN

The effect of methanolic extract of Vernonia cinerea L. on the immune system was studied using BALB/c mice. Intraperitoneal (i.p.) administration of five doses of the extract (20 mg/kg body weight) was found to enhance the total white blood cell (WBC) count (13,700 ± 463 cells/mm(3)) on 6th day, bone marrow cellularity (27.9 ± 2.1 × 10(6) cells/femur) and number of α-esterase positive cells (1184 ± 56.29/4000 cells). Treatment with V. cinerea along with the antigen, sheep red blood cells (SRBC), produced an enhancement in the circulating antibody titre and the number of plaque forming cells (PFC) in the spleen. Maximum number of PFC (304.16 ± 12.4) was obtained on the 6th day. It also enhanced the proliferation of splenocytes, thymocytes and bone marrow cells both in the presence and absence of specific mitogens in vitro and in vivo. Administration of V. cinerea significantly reduced the lipopolysaccharide (LPS) induced elevated levels of nitric oxide (NO) and proinflammatory cytokines such as tumor necrosis factor-α, interleukin-1 (IL-1ß), and IL-6 in mice. Treatment of V. cinerea methanolic extract also showed an enhancement in the phagocytic activity of peritoneal macrophages. Moreover The extract downregulated the inducible NO synthase and cyclooxygenase-2 (COX-2) mRNA expression in LPS-stimulated macrophages. These results indicate the immunomodulatory activity of V. cinerea.


Asunto(s)
Ciclooxigenasa 2/biosíntesis , Citocinas/biosíntesis , Factores Inmunológicos/farmacología , Macrófagos Peritoneales/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo II/biosíntesis , Vernonia/química , Animales , Anticuerpos/sangre , Células Productoras de Anticuerpos/efectos de los fármacos , Células Productoras de Anticuerpos/inmunología , Células de la Médula Ósea/citología , Células de la Médula Ósea/efectos de los fármacos , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/inmunología , Citocinas/genética , Citocinas/inmunología , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo , Ensayo de Inmunoadsorción Enzimática , Expresión Génica/efectos de los fármacos , Factores Inmunológicos/aislamiento & purificación , Leucocitos/citología , Leucocitos/efectos de los fármacos , Lipopolisacáridos/farmacología , Activación de Linfocitos/efectos de los fármacos , Macrófagos Peritoneales/inmunología , Ratones , Ratones Endogámicos BALB C , Óxido Nítrico Sintasa de Tipo II/genética , Óxido Nítrico Sintasa de Tipo II/inmunología , Tamaño de los Órganos/efectos de los fármacos , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Bazo/citología , Bazo/efectos de los fármacos , Bazo/inmunología , Timo/citología , Timo/efectos de los fármacos , Timo/inmunología
7.
Mem Inst Oswaldo Cruz ; 103(6): 569-77, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18949327

RESUMEN

Alternanthera tenella Colla extracts are used in Brazilian traditional folk medicine to treat a variety of infectious diseases as well as inflammation and fever. In this work, the immunomodulatory, anti-inflammatory and potential toxic effects of cold (CAE) and hot (HAE) aqueous extracts of A. tenella were investigated in vivo. In addition, we analyzed the phytochemical properties of both extracts. BALB/c mice were immunized in vivo with sheep red blood cells and concomitantly inoculated intraperitoneally (i.p.) with each extract (50, 100 or 200 mg/kg). Specific antibody-producing cells were enumerated using plaque-forming cell assays (PFC) and anti-SRBC IgG and IgM serum levels were measured via enzyme-linked immunosorbent assay. Body and lymphoid organ weights were determined after treatments in order to evaluate toxic effects. Carrageenan-induced paw edema was employed to investigate anti-inflammatory activity in mice inoculated i.p. with CAE or HAE (200 or 400 mg/kg). Phytochemical screening was performed using spectrometric and chromatographic approaches and revealed that CAE possessed higher tannin and flavonoid levels than HAE. PFC numbers were increased after treatment with CAE (100 mg/kg) four days after immunization, as were the serum antibody titers after four and seven days, suggesting immunostimulatory activity through modulation of B lymphocyte functions. Body and organ weights did not show major changes, suggesting that extracts administered to mice did not induce significant toxicity. Both extracts had significant anti-inflammatory activity in the paw edema assay. These results suggested that aqueous extracts from A. tenella contained several chemical compounds that possess positive and/or negative modulator effects on the immune system, which appeared to correlate with tannin and flavonoid levels in those extracts. In summary, these studies provide important insight into the biological activities of A. tenella.


Asunto(s)
Amaranthaceae/química , Antiinflamatorios/farmacología , Edema/tratamiento farmacológico , Factores Inmunológicos/farmacología , Extractos Vegetales/farmacología , Animales , Células Productoras de Anticuerpos/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Carragenina , Frío , Edema/inducido químicamente , Ensayo de Inmunoadsorción Enzimática , Calor , Ganglios Linfáticos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , Tamaño de los Órganos/efectos de los fármacos
8.
Mem. Inst. Oswaldo Cruz ; 103(6): 569-577, Sept. 2008. graf, tab, ilus
Artículo en Inglés | LILACS | ID: lil-495732

RESUMEN

Alternanthera tenella Colla extracts are used in Brazilian traditional folk medicine to treat a variety of infectious diseases as well as inflammation and fever. In this work, the immunomodulatory, anti-inflammatory and potential toxic effects of cold (CAE) and hot (HAE) aqueous extracts of A. tenella were investigated in vivo. In addition, we analyzed the phytochemical properties of both extracts. BALB/c mice were immunized in vivo with sheep red blood cells and concomitantly inoculated intraperitoneally (i.p.) with each extract (50, 100 or 200 mg/kg). Specific antibody-producing cells were enumerated using plaque-forming cell assays (PFC) and anti-SRBC IgG and IgM serum levels were measured via enzyme-linked immunosorbent assay. Body and lymphoid organ weights were determined after treatments in order to evaluate toxic effects. Carrageenan-induced paw edema was employed to investigate anti-inflammatory activity in mice inoculated i.p. with CAE or HAE (200 or 400 mg/kg). Phytochemical screening was performed using spectrometric and chromatographic approaches and revealed that CAE possessed higher tannin and flavonoid levels than HAE. PFC numbers were increased after treatment with CAE (100 mg/kg) four days after immunization, as were the serum antibody titers after four and seven days, suggesting immunostimulatory activity through modulation of B lymphocyte functions. Body and organ weights did not show major changes, suggesting that extracts administered to mice did not induce significant toxicity. Both extracts had significant anti-inflammatory activity in the paw edema assay. These results suggested that aqueous extracts from A. tenella contained several chemical compounds that possess positive and/or negative modulator effects on the immune system, which appeared to correlate with tannin and flavonoid levels in those extracts. In summary, these studies provide important insight into the biological activities of A. tenella.


Asunto(s)
Animales , Masculino , Ratones , Amaranthaceae/química , Antiinflamatorios/farmacología , Edema/tratamiento farmacológico , Factores Inmunológicos/farmacología , Extractos Vegetales/farmacología , Células Productoras de Anticuerpos/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Carragenina , Frío , Ensayo de Inmunoadsorción Enzimática , Edema/inducido químicamente , Calor , Ganglios Linfáticos/efectos de los fármacos , Ratones Endogámicos BALB C , Tamaño de los Órganos/efectos de los fármacos
9.
Rev Alerg Mex ; 53(6): 212-6, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17361755

RESUMEN

BACKGROUND: Hyperglycemia induces protein glycation, disturbing its function, additionally, the glycated products (AGEs) induce by themselves proinflammatory cytokine release that are responsible for insulin resistance. Glycine has been successfully used in diabetic patients to competitively reduce hemoglobin glycation. OBJECTIVES: To assess hyperglycemia impact on the immune response and to evaluate if it is possible to reverse it by means of glycine administration. MATERIAL AND METHODS: Streptozotocin-induced diabetic rats, with and without glycine administration were challenged with sheep red blood cells, and specific antibody producing cells were accounted. Normal rats were challenged as controls. RESULTS: Induced diabetes modifies significantly the humoral immune response capacity versus sheep red blood cells. Also, glycine administration prevents against this deleterious effect. CONCLUSIONS: Glycine could be an important therapeutic resource among diabetics to avoid the characteristic immunodeficiencies of this disease.


Asunto(s)
Formación de Anticuerpos/efectos de los fármacos , Diabetes Mellitus Experimental/inmunología , Glicina/uso terapéutico , Síndromes de Inmunodeficiencia/tratamiento farmacológico , Animales , Células Productoras de Anticuerpos/efectos de los fármacos , Células Productoras de Anticuerpos/inmunología , Glucemia/análisis , Diabetes Mellitus Experimental/complicaciones , Evaluación Preclínica de Medicamentos , Eritrocitos/inmunología , Hemoglobina Glucada/análisis , Productos Finales de Glicación Avanzada/análisis , Glicina/farmacología , Síndromes de Inmunodeficiencia/etiología , Masculino , Ratas , Ratas Wistar , Ovinos , Estreptozocina
10.
Immunopharmacol Immunotoxicol ; 25(4): 551-60, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14686797

RESUMEN

Various preparations of the plant Echinacea purpurea have been investigated for their potential to enhance immune function, primarily through activation of innate immune responses. Few studies have examined the potential for enhancement of humoral immunity. Using female Swiss mice we administered a volumetric dose of a glycerine extract of E. purpurea by oral gavage, to evaluate effects on the IgM specific antibody forming cell (AFC) response. Four days of treatment following immunization with sheep red blood cells (SRBC) produced a significant enhancement over naive controls at doses of 0.4 and 0.8 mL/kg/day. A few clinical trials and anecdotal reports have suggested that the greatest efficacy for E. purpurea occurs in acute use following onset of illness. A time course study, using the time of SRBC immunization to mimic the onset of illness, examined the effects of 8 and 4 days of E. purpurea treatment at 0.6 mL/kg/day. Only in the 4-day administration, with dosing beginning 1 hour after SRBC immunization, was there an observed enhancement of the antibody forming cell response. This supports the acute use of E. purpurea as suggested by anecdotal reports, and demonstrates the potential for enhancement of humoral immune responses as well as innate immune responses.


Asunto(s)
Echinacea , Inmunoglobulina M/biosíntesis , Adyuvantes Inmunológicos/farmacología , Animales , Células Productoras de Anticuerpos/efectos de los fármacos , Células Productoras de Anticuerpos/inmunología , Eritrocitos/inmunología , Femenino , Humanos , Inmunización , Ratones , Extractos Vegetales/farmacología , Ovinos
11.
Int Immunopharmacol ; 2(8): 1205-11, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12349957

RESUMEN

We investigated the immunopotentiating activities of boiled water-soluble extracts from desiccated Agaricus blazei Murill (ABM). Effect of ABM extract on antibody production was investigated by method of hemolytic plaque-forming cells (PFC) against sheep red blood cells (SRBC) antigen. ABM extracts significantly (p<0.01) increased the number of PFC in spleen with intraperitoneal administration at doses of 25 mg/kg as compared with control group. The populations of Mac-1- or CD25-positive cells significantly (p<0.01, p<0.001) increased, but in CD19-positive cells, there were no differences in ABM-treated mice as compared with control mice. The expressions of IL-6 and IL-1beta mRNA were augmented by ABM extract in both peritoneal macrophages and spleen cells. These results suggested that ABM extract might be an effective stimulator for T cell and macrophage to IL-1beta and IL-6 release, resulting in augmentation of antibody production against SRBC antigen.


Asunto(s)
Agaricus , Células Productoras de Anticuerpos/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Células Productoras de Anticuerpos/inmunología , Células Productoras de Anticuerpos/metabolismo , Femenino , Calor , Ratones , Ratones Endogámicos C57BL , Extractos Vegetales/aislamiento & purificación , Bazo/efectos de los fármacos , Bazo/inmunología , Bazo/metabolismo , Agua
12.
Arzneimittelforschung ; 52(6): 500-5, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12109052

RESUMEN

Pharmacological effects of mistletoe extracts are determined by the concentration of three toxic lectins: mistletoe lectin I (MLI, or viscumin), MLII, MLIII. These proteins, as well as ricin, belong to ribosome-inactivating proteins type 2 (RIP2). However, the extracts from the plant Ricinus communis, containing ricin, are highly toxic. Ricin is about 30 times more effective in cell culture than viscumin. The dissociation of subunits and the transmembrane transport of catalytic subunit into the cytoplasm are needed to obtain the cytotoxic effect of RIP2. In this paper, hybridomas producing monoclonal antibodies against catalytic subunits of ricin and viscumin are described. Monoclonal antibodies against different epitopes, including one localized in intra-subunit area of catalytic subunits of ricin and viscumin, do not inhibit the enzymatic activity of these proteins in cell-free system. These hybridomas are resistant to the cytotoxic action of native toxins. Protective effect of antibodies are about the same for both toxins, though the dissociation of the subunits of ricin is more effective. The causes of the differences in activity of plant toxins as pharmacological agents, and the importance of above mentioned epitopes for neutralizing antibodies at the clinical applications of mistletoe extracts are discussed.


Asunto(s)
Antineoplásicos Fitogénicos/toxicidad , Preparaciones de Plantas , Proteínas de Plantas , Ricina/toxicidad , Toxinas Biológicas/toxicidad , Animales , Anticuerpos Monoclonales/biosíntesis , Anticuerpos Monoclonales/química , Células Productoras de Anticuerpos/efectos de los fármacos , Antineoplásicos Fitogénicos/inmunología , Biotina/química , Supervivencia Celular/efectos de los fármacos , Ditiotreitol/farmacología , Epítopos/efectos de los fármacos , Hibridomas/efectos de los fármacos , Técnicas para Inmunoenzimas , Ratones , Proteínas Inactivadoras de Ribosomas Tipo 2 , Ricina/inmunología , Sales de Tetrazolio , Tiazoles , Toxinas Biológicas/inmunología
13.
Allergy ; 56(4): 293-300, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11284795

RESUMEN

BACKGROUND: Specific allergen immunotherapy (SIT) is effective for treatment of IgE-mediated diseases: however, the mechanisms of action still remain unclear. Earlier, we showed that IL-4 and IL-13 are produced in response to specific allergens. The aim of this study was to investigate whether these cytokine responses were affected by allergen SIT, and, furthermore, to evaluate the effect of SIT on allergen-specific IgE and IgG4 levels. METHODS: Blood samples from pollen-sensitized individuals were collected before the pollen season (before treatment) and during the pollen season (after SIT or placebo treatment). Peripheral blood mononuclear cells were activated in vitro with allergens and the numbers of IL-4-, IL-13-, IL-10-, and IFN-gamma-producing cells were determined by ELISPOT. Serum levels of allergen-specific IgE and IgG4 were measured by RAST and ELISA, respectively. RESULTS: The numbers of IL-4- and IL-13-producing cells were shown to be increased in the placebo group during the pollen season, an increment which was absent in patients receiving allergen SIT. We found an increase in allergen-specific IgG4 in the SIT-treated individuals, but not in the placebo group. Both groups displayed elevated specific IgE levels during the pollen season. CONCLUSIONS: Taken together, our data show a downregulation of IL-4- and IL-13-producing cells in peripheral blood after SIT, suggesting induction of nonresponsiveness/tolerance or a redistribution of these cells. Furthermore, we demonstrate that SIT acts on antibody production by increasing the specific IgG4 levels.


Asunto(s)
Células Productoras de Anticuerpos/efectos de los fármacos , Células Productoras de Anticuerpos/inmunología , Desensibilización Inmunológica , Interleucina-13/inmunología , Interleucina-4/inmunología , Polen/efectos adversos , Adulto , Método Doble Ciego , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Inmunoglobulina E/sangre , Inmunoglobulina E/efectos de los fármacos , Inmunoglobulina E/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina G/efectos de los fármacos , Inmunoglobulina G/inmunología , Interferón gamma/efectos de los fármacos , Interferón gamma/inmunología , Interleucina-10/inmunología , Masculino , Persona de Mediana Edad , Estaciones del Año
14.
Planta Med ; 67(2): 122-6, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11301856

RESUMEN

The effects of an acidic polysaccharide isolated from the ethanol-insoluble and water-soluble fraction of Panax ginseng C. A. Meyer on immunomodulating activities were investigated. A high output nitric oxide synthase (iNOS) was shown in female BALB/c mice administered intraperitoneally with the acidic polysaccharide from ginseng. Newly synthesized iNOS protein was also observed in peritoneal macrophages cultured with interferon-gamma and the acidic polysaccharide. Spleen cells from acidic polysaccharide-treated mice did not proliferate in response to concanavalin A, but restored the responsiveness by the cotreatment of NG-monomethyl-L-arginine (NMMA) with concanavalin A. The treatment of mice with aminoguanidine, a specific iNOS inhibitor, alleviated the acidic polysaccharide-induced suppression of antibody response to sheep red blood cells. Present results suggest that the immunomodulating activities of the acidic polysaccharide were mediated by the production of nitric oxide.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Óxido Nítrico/metabolismo , Panax/química , Plantas Medicinales , Polisacáridos/farmacología , Adyuvantes Inmunológicos/aislamiento & purificación , Animales , Células Productoras de Anticuerpos/efectos de los fármacos , Células Cultivadas/efectos de los fármacos , Células Cultivadas/inmunología , Concanavalina A/farmacología , Inducción Enzimática , Inhibidores Enzimáticos , Femenino , Guanidinas/toxicidad , Interferón gamma/metabolismo , Ratones , Ratones Endogámicos BALB C , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II , Lectinas de Plantas , Raíces de Plantas/química , Polisacáridos/aislamiento & purificación , Bazo/citología , Bazo/efectos de los fármacos , Bazo/inmunología , omega-N-Metilarginina/farmacología
15.
J Ethnopharmacol ; 71(1-2): 193-200, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10904163

RESUMEN

Administration of an extract from the powdered root of the plant Withania somnifera was found to stimulate immunological activity in Babl/c mice. Treatment with five doses of Withania root extract (20 mg/dose/animal; i.p.) was found to enhance the total WBC count (17125 cells/mm(3)) on 10th day. Bone marrow cellularity (27x10(6) cells/femur) as well as alpha-esterase positive cell number (1800/4000 cells) also increased significantly (P<0.001) after the administration of Withania extract. Treatment with Withania extract along with the antigen (SRBC) produced an enhancement in the circulating antibody titre and the number of plaque forming cells (PFC) in the spleen. Maximum number of PFC (985 PFC/10(6) spleen cells) was obtained on the fourth day. Withania extract inhibited delayed type hypersentivity reaction in mice (Mantoux test). Administration of Withania extract also showed an enhancement in phagocytic activity of peritoneal macrophages (76.5 pigmented cells/200) when compared to control (31.5/200 cells) in mice. These results confirm the immunomodulatory activity of W. somnifera extract, which is a known immunomodulator in indigenous medicine.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Plantas Medicinales/química , Solanaceae/química , Adyuvantes Inmunológicos/aislamiento & purificación , Animales , Anticuerpos/análisis , Células Productoras de Anticuerpos/efectos de los fármacos , Recuento de Células Sanguíneas/efectos de los fármacos , Células de la Médula Ósea/efectos de los fármacos , Esterasas/metabolismo , Hipersensibilidad Tardía/inmunología , India , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Tamaño de los Órganos/efectos de los fármacos , Fagocitosis/efectos de los fármacos , Raíces de Plantas/química , Estimulación Química
16.
Artículo en Ruso | MEDLINE | ID: mdl-10876901

RESUMEN

The prophylactic and therapeutic action of immunotropic preparations in different doses on the development of Pseudomonas infection of experimental animals with thermal burns was evaluated. Natural marrow and thymic regulatory peptides (myelopid, tactivin and thymalin), as well as the synthetic immunopreparation polyoxydonium, were used for immunocorrection. The study revealed that the injection of these immunomodulators in doses recommended by instructions for use did not affect the course of the infectious process, antibody production by immunocompetent cells and the death rate of experimental animals. The use of the course dose of any of these substances, introduced in a single injection, prevented the generalization of infection. The death rate of experimental animals dropped from 80.3% to 47.2%.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Quemaduras/complicaciones , Infecciones por Pseudomonas/prevención & control , Enfermedad Aguda , Animales , Células Productoras de Anticuerpos/efectos de los fármacos , Células Productoras de Anticuerpos/inmunología , Quemaduras/inmunología , Quemaduras/mortalidad , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Ratones , Ratones Endogámicos , Infecciones por Pseudomonas/etiología , Infecciones por Pseudomonas/inmunología , Infecciones por Pseudomonas/mortalidad , Ratas , Ratas Endogámicas , Bazo/efectos de los fármacos , Bazo/inmunología , Factores de Tiempo
17.
Drug Chem Toxicol ; 22(4): 655-77, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10536755

RESUMEN

Octamethylcyclotetrasiloxane, D4, is a low viscosity, silicone fluid consisting of four dimethyl-siloxy units ((CH3)2SiO)4 in a cyclic structure. It is primarily used as a building block in the industrial synthesis of long chain silicone polymers. The combination of D4 with decamethylcyclopentasiloxane (D5) is commonly referred to as cyclomethicone which has a wide range of applications as a formulation aid in personal care products. To extend the existing database regarding the biological activities of D4, a 28 day whole body vapor inhalation study was conducted using Fischer 344 rats at 0 (room air), 7, 20, 60, 180 and 540 ppm for 6 hours/day, 5 days/week. Parameters measured included body weights, organ weights, gross pathology, histopathology, serum chemistries, and urinalysis. In addition to these standard toxicological endpoints, the ability of D4 exposed animals to mount an IgM antibody response was evaluated by a splenic antibody forming cell (AFC) assay and a serum enzyme-linked immunosorbant assay (ELISA). The results of this 28-day inhalation study indicate that D4 exposure caused no adverse effects on body weight, food consumption, or urinalysis parameters. In addition, there were no exposure related histopathological alterations at any site for any exposure group. A statistically significant increase in liver weight and the liver to body weight ratio was observed in both male (180-540 ppm) and female (20-540 ppm) rats, which was not observed in the 14-day recovery group animals. There were no other significant organ weight changes. Although statistically significant changes were observed in several hematological and serum chemistry parameters in both the terminal and 14-day recovery animals, the changes were marginal and within the normal range of values for the rat. Under these experimental conditions, there were no alterations noted in immune system function at any of the D4 exposure levels.


Asunto(s)
Adyuvantes Inmunológicos/toxicidad , Células Productoras de Anticuerpos/efectos de los fármacos , Sistema Inmunológico/efectos de los fármacos , Hígado/efectos de los fármacos , Siloxanos/toxicidad , Adyuvantes Inmunológicos/química , Administración por Inhalación , Animales , Formación de Anticuerpos/efectos de los fármacos , Recuento de Células Sanguíneas/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática , Femenino , Inmunoglobulina M/análisis , Hígado/patología , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Endogámicas F344 , Siloxanos/química , Bazo/efectos de los fármacos , Bazo/inmunología , Pruebas de Toxicidad
19.
Eksp Klin Farmakol ; 61(5): 30-3, 1998.
Artículo en Ruso | MEDLINE | ID: mdl-9854630

RESUMEN

Five intraventricular injections of phytopreparations lohein and abisib in a dose of 0.2 or 0.5 ml stimulated dose-dependently the development of a T-dependent and T-independent immune responses in rats kept on the usual diet, and increased or normalized the development of these processes in rats kept on a atherogenic diet. The drugs lessened lipid peroxidation and the biochemical syndromes of hepatocyte affection in animals given an atherogenic diet. The immunomodulating effect of phytopreparations is mediated by cytokines of adherent and nonadherent splenic cells, the biochemical effects only by cytokines of adherent splenocytes.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Antioxidantes/uso terapéutico , Hiperlipidemias/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Árboles , Abies , Animales , Células Productoras de Anticuerpos/efectos de los fármacos , Células Productoras de Anticuerpos/inmunología , Dieta Aterogénica , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Hiperlipidemias/inmunología , Hiperlipidemias/metabolismo , Inmunidad Celular/efectos de los fármacos , Inmunización , Metabolismo de los Lípidos , Peroxidación de Lípido/efectos de los fármacos , Ratas , Ratas Wistar
20.
Acta Microbiol Immunol Hung ; 45(2): 221-8, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9768290

RESUMEN

The effect of trace element combination, Béres Drop Plus (BDP) on the immune response of rats following single treatment with cytostatic drug (5-fluorouracil, 5-FU) was tested. Animals were treated with 5-FU and SRBC simultaneously, but separately. Rats were pretreated with BDP for 21 days. The body and spleen weight, furthermore the number of spleen cells and antibody producing cells were determined. The antibody titres in blood serum were also measured. The immune system of rats, 5 days following the 5-FU treatment, showed considerable regeneration. Pretreatment of rats with BDP had a beneficial effect on all parameters investigated.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Células Productoras de Anticuerpos/efectos de los fármacos , Fluorouracilo/farmacología , Inmunosupresores/farmacología , Oligoelementos/farmacología , Zinc/farmacología , Animales , Peso Corporal/efectos de los fármacos , Combinación de Medicamentos , Eritrocitos/inmunología , Femenino , Inmunización , Minerales , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Wistar , Ovinos , Bazo/citología , Bazo/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA